The gut microbiome affects response of treatments in HER2‐negative advanced gastric cancer
Abstract Background Common treatments for metastatic/unresectable HER2‐negative gastric cancer include chemotherapy, immune checkpoint inhibitor monotherapy and chemotherapy plus immune checkpoint inhibitor. However, significant drug resistance exists regardless of the treatment regimen. Methods Pat...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2023-07-01
|
| Collection: | Clinical and Translational Medicine |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/ctm2.1312 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
